CME Credit Available: 

This activity offers 1.25 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• Physiology of bladder function and common pathology.
• Pharmacology and medication management of the lower urinary tract.
• Primary care management of PSA screening for male patients.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Joel Abbott, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.

CME Credit Available: 

This activity offers .75 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• Discuss clinical stratification for neurological cases.
• Discuss a general overview of multiple sclerosis.
• Discuss a general overview of types of strokes.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Scott L. Spradlin, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.

CME Credit Available: 

This activity offers 1.0 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• Common skin manifestations of gastrointestinal disease.
• Findings and symptoms of cutaneous disease in renal disorders.
• Common symptoms of endocrine disorders.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Molly Menser, DO, faculty for this activity, has disclosed the following financial relationships: 

• Loreal/Skin Ceuticals-honoraria-speaker

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.

CME Credit Available: 

This activity offers .25 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• To improve patients' health outcomes by choosing selected diets.
• To prevent exacerbations of selected conditions by prescribing appropriate diets.
• To educate patients on appropriate diets tailored to their comorbid conditions.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Robert T. Hasty, DO, FACOI, FACP, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.

CME Credit Available: 

This activity offers .5 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• Myopathies and treatments.
• Parkinson's, seizures, and motor disorders.
• Headaches and treatments.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Scott L. Spradlin, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.

CME Credit Available: 

This activity offers .5 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• Anticipate selected conditions based upon patients’ genetic disorders.
• Correlate genetic inheritance with selected conditions.
• Diagnose selected genetic conditions.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Robert T. Hasty, DO, FACOI, FACP, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.

CME Credit Available: 

This activity offers .5 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• How to work up and diagnose a polyneuropathy.
• How to work up an acute neuropathy.
• How to recognize and diagnose a mononeuropathy multiplex.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Scott L. Spradlin, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.

CME Credit Available: 

This activity offers .5 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• Guideline-based treatment for hypertension.
• The place of the SPRINT Trial in relation to hypertension treatment goals.
• The workup for hypertension.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

John E. Prior, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.

CME Credit Available: 

This activity offers .5 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• The approach to gapped metabolic acidosis.
• The use of the urine anion gap.
• The diagnosis and treatment approach to metabolic alkalosis.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

John E. Prior, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.

CME Credit Available: 

This activity offers .5 1A AOA

Note: ACOI reports credits to the AOA after the end of each quarter.  

Learning Objectives:

Those participating in this activity will receive information that should allow them to: 

• The key diagnostic features of Syndrome of inappropriate ADH secretion and appropriate treatments.
• The key diagnostic features of central and nephrogenic diabetes insipidus and appropriate treatments.
• The key diagnostic features of Gitelman's and Bartter's syndromes.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Mark D. Baldwin, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

Release & Review Date:

This activity is valid from July 31, 2024, until July 31, 2027.